AMANDA BERG

Allopathic & Osteopathic Physicians|Internal Medicine AVENTURA, FL NPI 1699984062

General Payments — all program years on this page

$4,779.40

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 255
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $322.41 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $322.4116

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,541.9070
2019 $1,730.6090
2020 $545.7239
2021 $371.0724
2022 $133.079
2023 $134.637
2024 $322.4116

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086762543 Novartis Pharmaceuticals Corporation $16.71 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096808850 Novo Nordisk Inc $21.99 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097710553 Novo Nordisk Inc $20.61 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103311128 ABBVIE INC. $14.67 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104373459 AstraZeneca Pharmaceuticals LP $15.95 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105696948 AstraZeneca Pharmaceuticals LP $18.80 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105765314 AstraZeneca Pharmaceuticals LP $16.91 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114590319 Exact Sciences Corporation $33.27 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114590323 Exact Sciences Corporation $24.12 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114590327 Exact Sciences Corporation $20.21 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116610074 GlaxoSmithKline, LLC. $21.17 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131724362 PFIZER INC. $20.99 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131724410 PFIZER INC. $13.41 05/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132105902 PFIZER INC. $21.56 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136027888 Lilly USA, LLC $17.99 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138832196 Edwards Lifesciences Corporation $24.05 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.